Insulin Glargine
21 Topics Found
Drug Index
Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a...
Drug Index
Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes. Contents 1 Medical use 1.1 Lixisenatide in neurodegenerative diseases 2 Adverse effects 3 Mechanism of action 4 Chemistry 5 History 6 References 7 External links Medical use Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes.[1] In the European Unio...
Drug Index
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.[2] It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin,&...
Drug Index
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.[2] It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin,&...
Insulin Glargine
Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a...
Insulin Glargine
Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a...
Insulin Glargine
Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a...
Insulin Glargine-aglr
Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a...
Insulin Degludec
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.[2] It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin,&...
Insulin Degludec + Insulin Aspart
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.[2] It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin,&...
I am a type 2 diabetic and I'm taking other diabetic meds along with Invocana. I'm taking other meds, such as Basaglar, and Victosa. Do these drugs interact negatively with the other diabetic drugs I'm taking? ## Hello Ladd, I was able to find 2 interactions between the medicines you listed. I have put both of them below. Basaglar (insulin glargine) -> Victoza (liraglutide) Using liraglutide together with insulin glargine can increase the risk of hypoglycemia, or low blood sugar. Let your doctor know if you experience hypoglycemia during treatment. Symptoms of hypoglycemia include headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Basaglar (insulin glargine) -> Invokana (canaglifl...
1 REPLY
Filed under
Basaglar
NDC Database
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p. ## Package Codes: 49502-393-80
NDC Database
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p. ## Package Codes: 49502-394-75
NDC Database
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p. ## Package Codes: 49502-195-80 ## Active Ingredients: Insulin Glargine
NDC Database
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p. ## Package Codes: 49502-196-75 ## Active Ingredients: Insulin Glargine
NDC Database
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p. ## Package Codes: 49502-250-80 ## Active Ingredients: Insulin Glargine
NDC Database
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p. ## Package Codes: 49502-251-75 ## Active Ingredients: Insulin Glargine
NDC Database
Toujeo 300 U/Ml Subcutaneous Injection, Solution by A-s Medication Solutions ## Package Codes: 50090-2193-0 ## Active Ingredients: Insulin Glargine
NDC Database
Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company ## Package Codes: 0002-7711-59 ## Active Ingredients: Insulin Glargine
NDC Database
Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions ## Package Codes: 50090-5835-0 ## Active Ingredients: Insulin Glargine